Gabon Pharmaceuticals and Healthcare Report Q2 2016
BMI View: Gabon's small pharmaceutical market size will continue to discourage investment frommultinational pharmaceutical companies. Over the long-term, the country's evolving demographic profile,boosts to domestic manufacturing capabilities, and the success of the national health insurance scheme willprovide momentum for pharmaceutical expenditure. However questions will be asked over the financialsustainability of the national health insurance scheme. Cost-containment measures are increasingly beingencouraged by the Gabonese government, shifting the market in favour of generic medicines, thussupporting domestic pharmaceutical production. However, Gabon will continue to rely on pharmaceuticalimports over the long-term.
Headline Expenditure Projections
Pharmaceuticals: XAF48.14bn (USD81mn) in 2015 to XAF51.04bn (USD83mn) in 2016; +6.0% inlocal currency and +3.1% in US dollar terms. Forecast unchanged from Q116.
Healthcare: XAF331.02bn (USD555mn) in 2015 to XAF358.69bn (USD585mn) in 2016; +8.4% inlocal currency and +5.4% in US dollar terms. Forecast unchanged from Q116.
- BMI Industry View
- Table: Headline Pharmaceuticals & Healthcare Forecasts (Gabon 2014-2020)
- SWOT
- Industry Forecast
- Pharmaceutical Market Forecast
- Table: Pharmaceutical Sales, Historical Data And Forecasts (Gabon 2012-2020)
- Healthcare Market Forecast
- Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Gabon 2012-2020)
- Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Gabon 2012-2020)
- Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Gabon 2012-2020)
- Pharmaceutical Trade Forecast
- Table: Pharmaceutical Trade Data And Forecasts local currency (Gabon 2014-2020)
- Table: Pharmaceutical Trade Data And Forecasts (Gabon 2014-2020)
- Industry Risk Reward Index
- Middle East and Africa Risk/Reward Index - Q2 2016
- Gabon Risk/Reward Index
- Rewards
- Risks
- Regulatory Review
- Regulatory Environment
- Regulatory Regime
- Intellectual Property Issues
- Pricing Regime
- Reimbursement Regime
- Market Overview
- Healthcare Sector
- Research & Development
- Clinical Trials
- Epidemiology
- Competitive Landscape
- Research-Based Industry
- Table: Multinational Market Activity
- Generic Drugmakers
- Pharmaceutical Distribution
- Pharmaceutical Retail Sector
- Demographic Forecast
- Table: Population Headline Indicators (Gabon 1990-2025)
- Table: Key Population Ratios (Gabon 1990-2025)
- Table: Urban/Rural Population & Life Expectancy (Gabon 1990-2025)
- Table: Population By Age Group (Gabon 1990-2025)
- Table: Population By Age Group % (Gabon 1990-2025)
- Glossary
- Methodology
- Pharmaceutical Expenditure Forecast Model
- Healthcare Expenditure Forecast Model
- Notes On Methodology
- Risk/Reward Index Methodology
- Index Overview
- Table: Pharmaceutical Risk/Reward Index Indicators
- Indicator Weightings
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook